NCT06851910 Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia
| NCT ID | NCT06851910 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital Universitari de Bellvitge |
| Condition | Trigeminal Neuralgia |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-04-21 |
| Primary Completion | 2026-12 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This prospective observational study evaluates the effectiveness and safety of intravenous lacosamide as a rescue treatment for acute pain in patients presenting to the emergency department with trigeminal neuralgia
Eligibility Criteria
All patients diagnosed with trigeminal neuralgia who present to the emergency department of Hospital de Bellvitge for an acute pain exacerbation and are prescribed intravenous lacosamide as symptomatic pain treatment, according to the treating physician's discretion, will be considered for inclusion. Inclusion Criteria: * Diagnosis of classical or idiopathic trigeminal neuralgia according to the criteria of the International Classification of Headache Disorders (ICHD-3). * Age over 18 years. * Signed informed consent. Exclusion Criteria: * Contraindication for treatment with lacosamide (previous hypersensitivity reaction, known atrioventricular block). * Mental or psychiatric illness that interferes with the ability to understand and sign the informed consent. * Language barrier. * Lack of cooperation.